secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiniMed Group, Inc. (MMED)
CIK:        0002062583
Form:       8-K
Filed at:   2026-06-03T10:50:57+00:00
Accession:  0001628280-26-040036
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiniMed Q4 net sales $837M (+16% as reported); FY27 organic growth guidance ~10%
--------------------------------------------------------------------------------

- Q4 net sales $837M (+15.6% as reported, +8.7% organic); International $599M (+22.4% as reported, +12.2% organic).
- Full FY26 net sales $3.102B (+14.2% as reported, +8.0% organic); first annual revenue >$3B.
- Worldwide New Pumps Sold ~42,000 in Q4 (+7.4% QoQ); FY26 total ~145,000 flat YoY; CGM attachment rate 66% (+700 bps YoY).
- FY27 guidance: organic revenue growth ~10% (including ~1.0-1.5% extra week benefit); adjusted EBITDA margin ~16%.
- Product milestones: MiniMed Flex FDA clearance, MiniMed Go US launch, extension of Abbott partnership for dual glucose-ketone sensors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2062583/000162828026040036/0001628280-26-040036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2062583/000162828026040036/mmed-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-040036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer